Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00236145
Status:
COMPLETED
Last Update Posted:
2013-01-29
First Post:
2005-10-07
Brief Title:
Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain
Sponsor:
Cephalon
Organization:
Teva Branded Pharmaceutical Products RD Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-06
Start Date Type:
None
Primary Completion Date:
2005-08
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2005-10-07
First Submit QC Date:
October 7 2005
Study First Post Date:
2005-10-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-01-28
Last Update Post Date:
2013-01-29
Last Update Post Date Type:
ESTIMATED